Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol/Acetaminophen vs Gabapentin for Painful Diabetic Neuropathy
NCT00634543Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2006
- Primary completion
- Oct 2008
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 4, randomised, open-label trial of tramadol hydrochloride + acetaminophen in diabetic neuropathy (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Change From Baseline in Pain Intensity Score at Day 43. Started Dec 2006; status: completed.
02
Drugs
tramadol hydrochloride + acetaminophen
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT00634543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634543.